Pharmacyclics (PCYC +1%) moves higher in today's trading on an upgrade to Buy at TheStreet,...
Pharmacyclics (PCYC +1%) moves higher in today's trading on an upgrade to Buy at TheStreet, citing the company's strong financials, "robust" revenue growth and a respectable return on equity.
From other sites
at CNBC.com (Jan 13, 2015)
at CNBC.com (Dec 5, 2014)
at CNBC.com (Sep 17, 2014)
at CNBC.com (Jul 29, 2014)
at CNBC.com (Jul 23, 2014)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs